This research was conducted by Prof. Hai Fang and team from Peking University and published in Expert Review of Vaccines, evaluates the health and economic impact of introducing the 13-valent PCV (PCV13) into immunization programs in Qinghai and Hainan. Using a decision tree-Markov model, the study simulated health benefits and lifetime costs under different vaccination strategies. The findings indicate that at current immunization coverage, PCV13 could significantly reduce disease cases and mortality, demonstrating cost-effectiveness across different pricing scenarios.
Pay-it-forward as a strategy to increase vaccine uptake
This research, conducted by Prof. Dan Wu from Nanjing Medical University and collaborators, was published in BMC Global and Public Health and focuses on the feasibility of the pay-it-forward strategy in increasing vaccine uptake.The commentary highlights that the pay-it-forward approach demonstrates scalability and cross-cultural adaptability, with the potential to be integrated with digital tools and government immunisation programs to promote equitable vaccine access and advance the goal of universal health coverage.